Come and join us across the globe
Dive into this conference at LINNC Paris 2024, as Adam ARTHUR discusses the increasing prevalence of Chronic Subdural Hematoma (CSDH) and the promising results of the Squid Embolization of the Middle Meningeal Artery (STEM) trial. Traditional treatments like craniotomy, burrhole drainage, and SEPS drainage have shown poor long-term outcomes. In contrast, the STEM trial explores MMA embolization with liquid embolic agents, demonstrating a significant reduction in failure rates.
